ReviewReviews in cardiovascular medicine2025
Transcatheter Edge-to-Edge Repair of Tricuspid Regurgitation With TriClip: A Step-by-Step Guide.
Review in Reviews in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The necessity for surgeons to embrace transcatheter tricuspid valve therapy.JTCVS structural and endovascular · 2026Article
- Echocardiographic guidance in transcatheter tricuspid valve interventions.Journal of cardiovascular imaging · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tricuspid regurgitation (TR), a condition that was once thought to be of little clinical importance, is now recognized as a progressive disease associated with increased morbidity and mortality. Despite the prevalence of TR, this condition remains undertreated due to the absence of effective medical therapy and high surgical risk. However, tricuspid transcatheter edge-to-edge repair (T-TEER) using the TriClip system has emerged as a new approach, offering a minimally invasive alternative for patients with symptomatic severe TR and prohibitive surgical risk. Thus, this comprehensive review outlines a step-by-step approach to TriClip implantation, encompassing anatomical and pathophysiological foundations, patient selection criteria, imaging protocols, and procedural techniques. Emphasis is placed on the critical role of transesophageal echocardiography for device guidance, leaflet grasping, and confirmation of procedural success. Moreover, key intra-procedural challenges and troubleshooting strategies are discussed in detail, along with post-procedural management, including antithrombotic therapy, imaging surveillance, and functional assessment. Comparative insights between TriClip and the PASCAL system are provided, highlighting technical and clinical differences, as well as implications for device selection. The emerging role of combined mitral and tricuspid TEER using a single steerable guide catheter is also explored, supported by early data suggesting the safety and efficacy of this combination. Evidence from randomized trials and real-world registries supports the safety, feasibility, and durability of TriClip-based T-TEER. Notably, as experience and technology continue to evolve, T-TEER is positioned to become a cornerstone in the management of functional TR in high-risk populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.